|
Paulson, Thomas G; Galipeau, Patricia C; Xu, Lianjun et al. (2008) p16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One 3:e3809
|
|
Chao, Dennis L; Sanchez, Carissa A; Galipeau, Patricia C et al. (2008) Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study. Clin Cancer Res 14:6988-95
|
|
Srivastava, Amitabh; Hornick, Jason L; Li, Xiaohong et al. (2007) Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol 102:483-93;quiz 694
|
|
Galipeau, Patricia C; Li, Xiaohong; Blount, Patricia L et al. (2007) NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med 4:e67
|
|
Chao, Dennis L; Maley, Carlo C; Wu, Xifeng et al. (2006) Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev 15:1935-40
|
|
Vaughan, Thomas L; Dong, Linda M; Blount, Patricia L et al. (2005) Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 6:945-52
|
|
Kraemer, Petra S; Sanchez, Carissa A; Goodman, Gary E et al. (2004) Flow cytometric enrichment for respiratory epithelial cells in sputum. Cytometry A 60:1-7
|
|
Maley, Carlo C; Galipeau, Patricia C; Li, Xiaohong et al. (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res 64:3414-27
|
|
Rudolph, Rebecca E; Vaughan, Thomas L; Kristal, Alan R et al. (2003) Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. J Natl Cancer Inst 95:750-7
|
|
Reid, Brian J; Blount, Patricia L; Rabinovitch, Peter S (2003) Biomarkers in Barrett's esophagus. Gastrointest Endosc Clin N Am 13:369-97
|
Showing the most recent 10 out of 38 publications
